Seonghoon Kim

Dr. Seonghoon Kim received his Ph.D. in the College of Pharmacy at Seoul National University in 2023. Throughout his doctoral studies, he actively participated in various experiments that focused on the anti-inflammation, anti-carcinogenesis, and antioxidant effects of Nrf2 and STAT3 signal pathways in acute/chronic inflammation and cancer. His research interests primarily lie in the molecular mechanism of immune cells and identifying homeostasis under acute/chronic inflammatory conditions and pathways associated with autoimmune disease and cancer. In September 2023, he joined Müschen lab as a postdoctoral associate interested in exploring the mechanism study of B-cell in cancer and identifying the therapeutic strategy and target for preventing autoimmune disease.